alpelisib
Showing 1 - 25 of 47
Characterize and Manage Hyperglycemia in Patients Initiating
Recruiting
- Metastatic Breast Cancer
- Alpelisib
- FreeStyle Libre 2 Continuous Glucose Monitor
-
Saint Louis Park, MinnesotaHealthPartners Cancer Research Center
Oct 16, 2023
Lymphatic Malformations Trial (Alpelisib, Placebo)
Not yet recruiting
- Lymphatic Malformations
- Alpelisib
- Placebo
- (no location specified)
Jul 4, 2023
Lymphangioma Trial in Albuquerque (Alpelisib)
Available
- Lymphangioma
- Alpelisib
-
Albuquerque, New MexicoUniversity of New Mexico - Cancer Center
Oct 4, 2022
Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)
Recruiting
- Advanced Breast Cancer
- Alpelisib
- Fulvestrant
-
Thalassery, Kerala, IndiaNovartis Investigative Site
Nov 21, 2022
PIK3CA-Related Overgrowth Spectrum (PROS) Trial in Worldwide (alpelisib)
Available
- PIK3CA-Related Overgrowth Spectrum (PROS)
- alpelisib
- (no location specified)
Sep 9, 2022
HR+, HER2-, Advanced Breast Cancer Trial (alpelisib)
Available
- HR+, HER2-, Advanced Breast Cancer
- alpelisib
- (no location specified)
Jul 5, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +3 more
- Alpelisib
- +7 more
- (no location specified)
Jul 28, 2023
Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,
Not yet recruiting
- Solid Tumors, Adult
- +7 more
- Alpelisib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 21, 2022
Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston
Recruiting
- Advanced Breast Carcinoma
- +17 more
- Alpelisib
- Enzalutamide
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- OP-1250
- +2 more
- (no location specified)
Aug 18, 2022
Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer Trial in
Recruiting
- Hormone Receptor Positive Breast Carcinoma
- +2 more
- Alpelisib
- +2 more
-
Chicago, Illinois
- +2 more
Jul 1, 2022
Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)
Active, not recruiting
- Breast Cancer, PI3K, Alpelisib
- Alpelisib
- Chemotherapy
-
Angers, France
- +13 more
Mar 8, 2022
Breast Cancer Trial in United States (Alpelisib, Sacituzumab govitecan)
Recruiting
- Breast Cancer
- Alpelisib
- Sacituzumab govitecan
-
Fairway, Kansas
- +6 more
Apr 4, 2022
CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell
Recruiting
- CDKN2A-p16 Positive
- +5 more
- Alpelisib
- +3 more
-
Tucson, ArizonaThe University of Arizona Medical Center-University Campus
Mar 7, 2022
HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)
Recruiting
- HER2-positive Metastatic Breast Cancer
- Alpelisib
- +2 more
-
Aurora, Colorado
- +2 more
Dec 29, 2022
Solid Tumor, Stomach Cancer Trial in Seongnam-si, Seoul (Alpelisib, Paclitaxel)
Recruiting
- Solid Tumor
- Stomach Cancer
- Alpelisib
- Paclitaxel
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Aug 21, 2021
Breast Tumors Trial in China (Alpelisib, Fulvestrant, Placebo)
Recruiting
- Breast Neoplasms
- Alpelisib
- +2 more
-
Hefei, Anhui, China
- +31 more
Dec 19, 2022
Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)
Not yet recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jun 28, 2023
Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Elacestrant
- +4 more
- (no location specified)
Sep 28, 2022
HR+ Advanced or Metastatic Breast Cancer Trial (alpelisib)
No longer available
- HR+ Advanced or Metastatic Breast Cancer
- alpelisib
- (no location specified)
Jul 13, 2021
Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)
Recruiting
- Cancer
- Trametinib
- +14 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Nov 4, 2022